Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

Hans-Dirk Düngen; Lars Kober; Savina Nodari; Morten Schou; Christiane Otto; Michael Becka; Friederike Kanefendt; Bernhard R. Winkelmann; Gunnar Gislason; Frank Richard; Olav Wendelboe Nielsen; Mihai Gheorghiade; Michele Senni

doi:10.1002/cpdd.633

Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

Hans-Dirk Düngen, Lars Kober, Savina Nodari, Morten Schou, Christiane Otto, Michael Becka, Friederike Kanefendt, Bernhard R. Winkelmann, Gunnar Gislason, Frank Richard, Olav Wendelboe Nielsen, Mihai Gheorghiade, Michele Senni

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

18 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Clinical Pharmacology in Drug Development
Vol/bind	8
Udgave nummer	7
Sider (fra-til)	942-951
Antal sider	10
ISSN	2160-763X
DOI	https://doi.org/10.1002/cpdd.633
Status	Udgivet - 2019

Adgang til dokumentet

10.1002/cpdd.633

Citationsformater

Düngen, H.-D., Kober, L., Nodari, S., Schou, M., Otto, C., Becka, M., Kanefendt, F., Winkelmann, B. R., Gislason, G., Richard, F., Nielsen, O. W., Gheorghiade, M., & Senni, M. (2019). Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial. Clinical Pharmacology in Drug Development, 8(7), 942-951. https://doi.org/10.1002/cpdd.633

Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial. / Düngen, Hans-Dirk; Kober, Lars; Nodari, Savina et al.
I: Clinical Pharmacology in Drug Development, Bind 8, Nr. 7, 2019, s. 942-951.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Düngen, H-D, Kober, L, Nodari, S, Schou, M, Otto, C, Becka, M, Kanefendt, F, Winkelmann, BR, Gislason, G, Richard, F, Nielsen, OW, Gheorghiade, M & Senni, M 2019, 'Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial', Clinical Pharmacology in Drug Development, bind 8, nr. 7, s. 942-951. https://doi.org/10.1002/cpdd.633

@article{6c50b3f03f7b43f6b328e77442e8ff88,

title = "Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial",

author = "Hans-Dirk D{\"u}ngen and Lars Kober and Savina Nodari and Morten Schou and Christiane Otto and Michael Becka and Friederike Kanefendt and Winkelmann, {Bernhard R.} and Gunnar Gislason and Frank Richard and Nielsen, {Olav Wendelboe} and Mihai Gheorghiade and Michele Senni",

year = "2019",

doi = "10.1002/cpdd.633",

language = "English",

volume = "8",

pages = "942--951",

journal = "Clinical Pharmacology in Drug Development",

issn = "2160-763X",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

AU - Düngen, Hans-Dirk

AU - Kober, Lars

AU - Nodari, Savina

AU - Schou, Morten

AU - Otto, Christiane

AU - Becka, Michael

AU - Kanefendt, Friederike

AU - Winkelmann, Bernhard R.

AU - Gislason, Gunnar

AU - Richard, Frank

AU - Nielsen, Olav Wendelboe

AU - Gheorghiade, Mihai

AU - Senni, Michele

PY - 2019

Y1 - 2019

U2 - 10.1002/cpdd.633

DO - 10.1002/cpdd.633

M3 - Journal article

C2 - 30452784

SN - 2160-763X

VL - 8

SP - 942

EP - 951

JO - Clinical Pharmacology in Drug Development

JF - Clinical Pharmacology in Drug Development

IS - 7

ER -